ストックスクリーナーアプリを入手
1.06
0.00%
0.00
アフターアワーズ：
1.04
-0.02
-1.89%
前日終値:
$1.06
開ける：
$1.08
24時間の取引高:
2.60M
Relative Volume:
0.75
時価総額：
$47.08M
収益：
-
当期純損益:
$-51.50M
株価収益率:
-0.265
EPS:
-4
ネットキャッシュフロー:
$-47.10M
1週間 パフォーマンス:
+9.14%
1か月 パフォーマンス:
+24.53%
6か月 パフォーマンス:
-13.11%
1年 パフォーマンス:
-80.15%
1日の値動き範囲:
$1.04
$1.11
1週間の範囲:
$0.928
$1.1899
52週間の値動き範囲:
$0.79
$6.98
Outlook Therapeutics Inc Stock (OTLK) Company Profile
名前
Outlook Therapeutics Inc
セクター
電話
(609) 619-3990
住所
111 S. WOOD AVENUE, ISELIN, NJ
OTLK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OTLK
Outlook Therapeutics Inc
|
1.06 | 47.08M | 0 | -51.50M | -47.10M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Outlook Therapeutics Inc Stock (OTLK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-08-28 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-12-02 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2024-03-27 | アップグレード | BTIG Research | Neutral → Buy |
| 2024-02-15 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2024-01-25 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-12-27 | アップグレード | CapitalOne | Equal Weight → Overweight |
| 2023-08-31 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2023-08-31 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-08-30 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-08-30 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-08-30 | ダウングレード | CapitalOne | Overweight → Equal Weight |
| 2023-08-30 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-07-13 | 開始されました | CapitalOne | Overweight |
| 2023-04-03 | 開始されました | Guggenheim | Buy |
| 2023-02-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-10-31 | 開始されました | BTIG Research | Buy |
| 2022-09-13 | 開始されました | Chardan Capital Markets | Buy |
| 2019-09-11 | 開始されました | Ladenburg Thalmann | Buy |
| 2019-05-16 | 開始されました | Oppenheimer | Outperform |
| 2019-04-22 | 開始されました | Ascendiant Capital Markets | Buy |
すべてを表示
Outlook Therapeutics Inc (OTLK) 最新ニュース
Can Outlook Therapeutics Inc. stock continue upward trendWeekly Profit Analysis & Weekly High Momentum Picks - newser.com
OTLK Receives Neutral Rating from HC Wainwright & Co. | OTLK Sto - GuruFocus
H.C. Wainwright maintains Neutral rating on Outlook Therapeutics stock - Investing.com India
Is Outlook Therapeutics Inc. (41ON) stock good for long term investing2025 EndofYear Setup & Technical Confirmation Alerts - newser.com
Outlook Therapeutics plans FDA BLA resubmission for wet AMD treatment By Investing.com - Investing.com Nigeria
What analysts say about Outlook Therapeutics Inc stockBlue Chip Stock Analysis & Discover Stocks Experts Are Watching - earlytimes.in
Outlook Therapeutics stock price target raised to $13 from $8 at Brookline Capital - Investing.com Nigeria
Outlook Therapeutics Completes FDA Meeting on ONS-5010 - TipRanks
Outlook Therapeutics Plans to Resubmit ONS-5010 Biologics License Application Before Year-End - MarketScreener
Outlook Therapeutics Stock: To Buy or Not? - StocksToTrade
Why Outlook Therapeutics Inc. (41ON) stock is favored by hedge fundsWeekly Investment Recap & Fast Entry Momentum Trade Alerts - newser.com
How to recover losses in Outlook Therapeutics Inc. stockTrade Exit Report & AI Powered Market Trend Analysis - newser.com
Outlook Therapeutics stock surges after productive FDA meeting By Investing.com - Investing.com Nigeria
Outlook Therapeutics stock surges after productive FDA meeting - Investing.com India
Can Outlook Therapeutics Inc. rally from current levelsTrade Analysis Report & Momentum Based Trading Ideas - newser.com
What is the fair value of Outlook Therapeutics Inc. stock nowGold Moves & Low Drawdown Momentum Trade Ideas - newser.com
How Outlook Therapeutics Inc. (41ON) stock moves in volatile trading sessions - newser.com
Outlook Therapeutics (OTLK) Engages in Constructive Talks with F - GuruFocus
Outlook Therapeutics (OTLK) Aims for BLA Resubmission by Year-En - GuruFocus
Outlook Therapeutics provides update on Type A Meeting with FDA - MarketScreener
Is Outlook Therapeutics Inc. (41ON) stock attractive for growth fundsOptions Play & Verified Swing Trading Watchlist - newser.com
Outlook Therapeutics plans FDA BLA resubmission for wet AMD treatment - Investing.com India
Outlook Therapeutics Provides Update On Type A Meeting With FDA - TradingView
Outlook Therapeutics Provides Update on Type A Meeting with FDA - GlobeNewswire
How Outlook Therapeutics Inc. (41ON) stock expands through international marketsJuly 2025 Outlook & Real-Time Stock Price Movement Reports - newser.com
Outlook Therapeutics, Inc. Announces Type A Meeting with the U.S. Food and Drug Administration Resubmission for Ons-5010 - MarketScreener
Market reaction to Outlook Therapeutics Inc.’s recent newsJuly 2025 Action & Technical Pattern Based Buy Signals - newser.com
What drives Outlook Therapeutics Inc 41ON stock priceFundamental Stock Analysis & Easy Tools to Analyze Your Investment Risk - earlytimes.in
How Outlook Therapeutics Inc. stock performs in interest rate cyclesJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com
OTLK: Ascendiant Capital Lowers Price Target While Maintaining B - GuruFocus
Outlook Therapeutics, Inc.(NasdaqCM: OTLK) dropped from S&P Global BMI Index - MarketScreener
IPO Launch: What is RIBBR’s valuation compared to sectorWall Street Watch & Pattern Based Trade Signal System - khodrobank.com
Exit Recap: Is Outlook Therapeutics Inc. stock trending bullishEarnings Miss & Capital Efficient Trading Techniques - khodrobank.com
What data driven models say about Outlook Therapeutics Inc.’s future2025 Top Decliners & Reliable Price Breakout Alerts - newser.com
Sentiment Watch: Is Outlook Therapeutics Inc. showing insider buying2025 EndofYear Setup & Short-Term High Return Strategies - خودرو بانک
Performance Recap: Is Outlook Therapeutics Inc a top pick in the sector2025 Valuation Update & Weekly Watchlist for Consistent Profits - خودرو بانک
Applying sector rotation models to Outlook Therapeutics Inc.Take Profit & Verified Momentum Watchlists - newser.com
Short interest data insights for Outlook Therapeutics Inc.Long Setup & Advanced Technical Analysis Signals - newser.com
Published on: 2025-09-19 03:10:54 - خودرو بانک
Breakout Move: Is Outlook Therapeutics Inc forming a bullish divergenceLayoff News & Free Accurate Trade Setup Notifications - خودرو بانک
Largest borrow rate increases among liquid names - TipRanks
Bull Bear: Does Outlook Therapeutics Inc have consistent dividend growthProduct Launch & Weekly Stock Breakout Alerts - خودرو بانک
Growth Recap: Can Outlook Therapeutics Inc. navigate macro headwindsBear Alert & Real-Time Price Movement Reports - خودرو بانک
Aug Summary: Does Outlook Therapeutics Inc have strong EBITDA margins2025 Trading Volume Trends & Weekly High Return Forecasts - خودرو بانک
Movement Recap: Should you buy the dip on Outlook Therapeutics IncTrade Ideas & Weekly Top Gainers Alerts - خودرو بانک
Is Senseonics Holdings Inc forming bullish engulfing patternsPortfolio Profit Report & Fast Gaining Stock Reports - خودرو بانک
AI Stocks: How does Outlook Therapeutics Inc perform in inflationary periodsTrade Entry Report & Fast Momentum Stock Entry Tips - خودرو بانک
VIX Spike: Is Outlook Therapeutics Inc a top pick in the sectorJuly 2025 WrapUp & Capital Efficiency Focused Strategies - خودرو بانک
Sentiment Watch: Is Outlook Therapeutics Inc in a long term uptrend2025 Volume Leaders & High Yield Equity Trading Tips - خودرو بانک
Dip Buying: Is Outlook Therapeutics Inc forming a bullish divergenceWeekly Gains Report & Verified Entry Point Detection - خودرو بانک
Aug EndMonth: Will Outlook Therapeutics Inc benefit from government policySwing Trade & Low Risk Entry Point Guides - خودرو بانک
Outlook Therapeutics Inc (OTLK) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):